Clinical Trial Update: Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of tamoxifen, carboplatin, and topotecan in patients with brain or spinal CNS tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Cancer
• Central Nervous System Cancer

Drugs mentioned

• Hycamtin (Topotecan)
• Nolvadex (tamoxifen)
• Paraplatin (Carboplatin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 2 | Status: COMPLETED